The PROTECT Study: 35 Months of Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients

Schlitt, H. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Neuhaus, P. and Schemmer, P. and Fischer, L. and Paulus, E. and Mertens, M. and Sterneck, M. (2013) The PROTECT Study: 35 Months of Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 13 (Suppl5). p. 130. ISSN 1600-6135, 1600-6143

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Depositing User: Petra Gürster
Date Deposited: 28 May 2020 08:04
Last Modified: 28 May 2020 08:04
URI: https://pred.uni-regensburg.de/id/eprint/16875

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.